Chronic Pain
Study register · detail Systematic Review · Chronic Pain · 2024

Effectiveness of Cannabidiol to Manage Chronic Pain: A Systematic Review.

Mixed GRADE High 22 citations
Samplek = 15 Studien
Durationuntil August 30, 2022
EndpointPain intensity
Blindingunklar
DesignSystematic Review
Key finding

The majority of studies showed pain reduction of 42–66 % with CBD alone or CBD with THC, but three studies showed no significant improvement and one had mixed results.

Summary

Systematic review on CBD in chronic pain; k=15 studies from 1.516 identified articles. Majority of studies showed pain reduction of 42%–66% with CBD alone or CBD+THC; 3 studies without significant improvement, 1 with mixed findings. Pain assessment mainly via self-report and VAS/VNS.

P
PopulationAdults with chronic pain (various etiologies), pooled from 15 studies
I
InterventionCannabidiol (CBD) alone or in combination with tetrahydrocannabinol (THC), various forms of administration
O
OutcomePain reduction of 42–66 % in the majority of studies; 3 studies without significant improvement, 1 study with mixed findings
Confidence in the evidence
High

The highest of four GRADE levels, the effect estimate is very reliable.

Quality profile
Sample size
Blinding
Effect size Mixed
Citations / year
Authors
Mohammed SYM, Leis K, Mercado RE, Castillo MMS, Miranda KJ, Carandang RR
DOI 10.1016/j.pmn.2023.10.002
Design: Systematic Review
Share
Abstract
Objectives: Cannabidiol (CBD), a component in Cannabis, is used to treat seizures, anxiety, and pain. Little is known about how effectively CBD works in managing chronic pain, a condition characterized by discomfort that persists beyond 3-6 months or beyond expected normal healing. Therefore, this systematic review aimed to synthesize evidence on the effectiveness of CBD in chronic pain management. Design: A systematic review of literature utilizing PRISMA 2020 guidelines. Data Sources: PubMed/MEDLINE, Web of Science, CINAHL, Academic Search Complete, PsycArticles, PsycINFO, SocINDEX, and CENTRAL. The gray literature search was performed through the World Health Organization, the Centers for Disease Control and Prevention, and the European Centre for Disease Prevention and Control. Review/Analysis Methods: We searched eight databases and gray literature for relevant studies until August 30, 2022. We gathered original research articles with various study designs published in English that looked at patients who used CBD to manage their chronic pain. Two authors assessed the risk of bias and certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used narrative synthesis to analyze the results. Results: We included 15 studies among 1,516 identified articles. The majority of the studies indicated pain reduction ranging from 42% - 66% with CBD alone and CBD with Tetrahydrocannabinol. Three studies showed no significant improvement in reducing pain, and one had mixed findings in pain control. The included studies had various methods of measuring pain reduction, mostly through self-reporting and scales such as visual analog scales and verbal numerical scales, among others. Conclusion: CBD may be useful in treating chronic pain. Findings should be interpreted with caution due to the small number of included studies and heterogeneity brought about by different study designs and outcome measures. More studies with robust study designs are warranted to evaluate CBD's effectiveness in treating chronic pain.

The impediment to action advances action. — Marcus Aurelius